Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 20 open reading frame 69 pseudogene (C20orf69 pseudogene, ENSG00000226838) is annotated as a pseudogene on human chromosome 20. Pseudogenes are defined as genomic sequences similar to functional genes but incapable of encoding a functional protein—typically due to frameshifts, truncations, or disabling mutations. While long considered “junk DNA,” some pseudogenes have been shown to regulate gene expression through RNA-mediated mechanisms, such as acting as microRNA sponges or generating regulatory small RNAs, though such functions are context- and locus-specific and not established for C20orf69 pseudogene itself. There is no evidence that C20orf69 pseudogene encodes a functional protein, serves as a therapeutic target, or participates directly in human disease. It is included in reference genomics databases for completeness of genomic annotation and evolutionary studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 20 open reading frame 69 pseudogene (C20orf69 pseudogene).